Seasoned healthcare and growth-stage investor with experience in private equity, venture and portfolio company operating roles.
Matthew Ottusch is a senior investor and board director who has led deal sourcing, due diligence, growth initiatives, and exits across healthcare services and healthtech.
Focuses on value creation through commercial scale-up, strategic M&A and operational improvements; engages with LPs on fundraising and portfolio governance.
Seasoned healthcare and growth-stage investor with experience in private equity, venture and portfolio company operating roles.
Matthew Ottusch is a senior investor and board director who has led deal sourcing, due diligence, growth initiatives, and exits across healthcare services and healthtech.
Focuses on value creation through commercial scale-up, strategic M&A and operational improvements; engages with LPs on fundraising and portfolio governance.
Invests primarily in growth-stage healthcare services and healthtech, applying a value-oriented growth lens that emphasizes commercial scale-up, strategic M&A and operational transformation. Allocates capital toward companies with durable clinical economics and scalable go-to-market models, favoring board-level engagement and staged commitments tied to KPI-driven milestones. Time horizon is multi-year with active governance to de-risk execution; underwriting centers on revenue unit economics, management depth, clear exit pathways and repeatable integration playbooks.
Invests primarily in growth-stage healthcare services and healthtech, applying a value-oriented growth lens that emphasizes commercial scale-up, strategic M&A and operational transformation. Allocates capital toward companies with durable clinical economics and scalable go-to-market models, favoring board-level engagement and staged commitments tied to KPI-driven milestones. Time horizon is multi-year with active governance to de-risk execution; underwriting centers on revenue unit economics, management depth, clear exit pathways and repeatable integration playbooks.
| Trades 567 | Longs Won 376/567 66% | Profit Factor 6.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $158,992.79 |
| Average Win $76,985.25 | Best Trade (Oct 15) $1.38M | Sharpe Ratio -10.64 |
| Average Loss -$23,003.01 | Worst Trade (Oct 14) -$809,229.21 | Z-Score 7.07 (100%) |
| Commissions $0 | Avg. Trade Length 11m 3d | Expectancy $40,915.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,452 | 5,806 | 5,161 | 4,516 | 3,871 | 3,226 | 2,581 | 1,935 | 1,290 | 645 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 7840 78409V112 | 1,125 | $458,240 | $458,240 | - | - | - | 0.0 |
AAPL Apple Inc. | 6,227 | $1.55M | $2.14M | - | $586,496.45 | 37.86% | -0.003% |
ABT Abbott Laboratories | 2,698 | $357,889.83 | $282,993.22 | - | -$74,896.61 | -20.93% | +1.865% |
ACIO Aptus Collared Investment Opportunity ETF | 313,908 | $12.75M | $14.85M | - | $2.1M | 16.47% | +0.297% |
ACN Accenture plc Class A | 2,939 | $708,619.95 | $659,335.26 | - | -$49,284.69 | -6.96% | +4.364% |
ADI Analog Devices, Inc. | 1,221 | $388,448.8 | $491,824.9 | - | $103,376.1 | 26.61% | -0.19% |
ADME Aptus Drawdown Managed Equity Fund | 35,977 | $1.72M | $2.03M | - | $313,643.73 | 18.23% | +0.462% |
ADP Automatic Data Processing Inc. | 2,768 | $749,225.18 | $795,135.68 | - | $45,910.5 | 6.13% | +2.476% |
AFL Aflac Inc. | 4,961 | $519,898.34 | $586,290.98 | - | $66,392.64 | 12.77% | -0.025% |
AMZN Amazon.com Inc | 945 | $225,288 | $241,258.5 | - | $15,970.5 | 7.09% | +0.48% |
AVGO Broadcom Inc. | 1,749 | $546,475.4 | $600,116.88 | - | $53,641.48 | 9.82% | -0.904% |
AVNV Avantis All International Markets Value ETF | 4,658 | $365,327 | $390,666.46 | - | $25,339.46 | 6.94% | +0.624% |
AVUV Avantis U.S. Small Cap Value ETF | 2,865 | $269,660.16 | $344,774.1 | - | $75,113.94 | 27.86% | +0.965% |
BLK BlackRock, Inc. | 356 | $342,108.84 | $397,609.28 | - | $55,500.44 | 16.22% | +4.013% |
BOXX Alpha Architect 1-3 Month Boxx Fund | 3,738 | $437,682 | $443,345.49 | - | $5,663.49 | 1.29% | +0.033% |
BRK-A Berkshire Hathaway Inc. | 1 | $680,920 | $792,170.01 | - | $111,250.01 | 16.34% | +0.327% |
BTC Grayscale Bitcoin Mini Trust ETF | 106,264 | $3.27M | $4.12M | - | $849,183.87 | 26% | +49.249% |
CALF Pacer US Small Cap Cash Cows 100 ETF | 25,898 | $1.13M | $1.46M | - | $333,213.68 | 29.49% | +2.495% |
CAT Caterpillar Inc. | 449 | $176,145.76 | $330,257.46 | - | $154,111.7 | 87.49% | -1.794% |
CB Chubb Limited | 1,480 | $417,742.69 | $524,586 | - | $106,843.31 | 25.58% | +1.228% |